Related Experiment Videos
Hemolytic anemia following succimer administration in a glucose-6-phosphate dehydrogenase deficient patient
1Division of Environmental and Occupational Health, Emory University School of Public Health, Atlanta, GA 30329.
Journal of Toxicology. Clinical Toxicology
|January 1, 1994
Abstract:
Because of its favorable side effects profile, the oral chelating agent dimercaptosuccinic acid is often used for treatment of lead intoxication. We report a case of a 45-year-old black male with glucose-6-phosphate dehydrogenase deficiency and a 17 year history of occupational lead exposure who developed hemolysis during treatment with dimercaptosuccinic acid for symptomatic lead intoxication.